Minority issues in prostate disease

Medical Clinics of North America

Volumn 89, Issue 4, 2005, Pages 805-816

  French, Dan B ^a   Jones, LeRoy A ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CYTOCHROME P450 3A4; OXIDOREDUCTASE;

AFRICAN AMERICAN; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; ENVIRONMENTAL FACTOR; HEALTH CARE SYSTEM; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; REVIEW; SOCIOECONOMICS;

HUMANS; MALE; MINORITY GROUPS; PATIENT SELECTION; PROSTATIC DISEASES; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 19944376549     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2005.02.003     Document Type: Review

References (31)

1. J.N. Krieger, L.J. Nyberg, and J.C. Nickel NIH consensus definition and classification of prostatitis JAMA 282 1999 236 237
2. I.D. Flemming J.S. Cooper D.E. Hemson American Joint Committee on Cancer Staging Manual 5th edition 1997 JP Lippincott Philadelphia 219 222
3. National Cancer Institute. Prostate-US racial/ethnic patterns. Available at: http://www.cancer.gov/statistics/cancertype/prostate-racial-ethnic. Accessed July 14, 2004.
4. Surveillance, epidemiology, and end results cancer statistics review, 1975-2001. Available at: http://seer.cancer.gov/csr/1975_2001/results_merged/ sect_22_prostate.pdf. Accessed July 14, 2004.
5. A. Zietman, J. Moughan, and J. Owen The patterns of care survey of radiation therapy in localized prostate cancer: similarities between the practice nationally and in minority-rich areas Int J Radiat Oncol Biol Phys 50 2001 75 80
6. R.E. Reiter, and J.B. Dekernion Epidemiology, etiology, and prevention of prostate cancer P.C. Walsh A.B. Retik E.D. Vaughan Epidemiology, etiology, and prevention of prostate cancer. 8th edition (Cambell's urology) 2002 WB Saunders Philadelphia 3004
7. D.N. Osegbe Prostate cancer in Nigerians: facts and nonfacts J Urol 157 1997 1340
8. R.E. Reiter, and J.B. Dekernion Epidemiology, etiology, and prevention of prostate cancer P.C. Walsh A.B. Retik E.D. Vaughan Epidemiology, etiology, and prevention of prostate cancer. 8th edition (Cambell's urology) 2002 WB Saunders Philadelphia 3007
9. R.K. Ross, L. Bernstein, and R.A. Lobo 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males Lancet 339 1992 887 889
10. R.E. Henderson, and H.S. Fiegelson Hormonal carcinogenesis Carcinogenesis 21 2000 427 433
11. T.R. Rebbeck, J.M. Jaffe, and A.H. Walker Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 J Natl Cancer Inst 90 1998 1225 1229
12. Y. Ando, T. Tateishi, and Y. Sekido Re: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 J Natl Cancer Inst 91 1999 1587 1589
13. R.E. Reiter, and J.B. Dekernion Epidemiology, etiology, and prevention of prostate cancer P.C. Walsh A.B. Retik E.D. Vaughan Epidemiology, etiology, and prevention of prostate cancer. 8th edition (Cambell's urology) 2002 WB Saunders Philadelphia 3008
14. O. Sartor, Q. Zheng, and J.A. Eastham Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer Urology 53 1999 378
15. S. Reddy, M. Shapiro, and R. Morton Prostate cancer on black and white Americans Cancer Metastasis Rev 22 2003 83 86
16. V.L. Shavers, M.L. Brown, and C. Klabunde Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer J Gen Intern Med 19 2004 146 155
17. V.L. Shavers, M. Brown, and C.M. Klabunde Race/ethnicity and the intensity of medical monitoring under watchful waiting for prostate cancer Med Care 42 2004 239 250
18. S.A. Optenberg, I.M. Thompson, and P. Friedrichs Race, treatment and longterm survival from prostate cancer in an equal access medical delivery system JAMA 274 1995 1599 1605
19. M.A. Diefenbach, N. Hamrick, and R. Uzzo Clinical, demographic, and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer J Urol 170 2003 166 169
20. C.L. Amling, C.J. Kane, and R.H. Riffenburgh Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy Urology 58 2001 723 728
21. C.L. Amling, R.H. Riffenburgh, and S. Leon Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy J Clin Oncol 22 2004 439 445
22. E.L. Paquette, R.R. Connelly, and I.A. Sesterhenn Improvements in pathologic staging for African American men undergoing radical retropubic prostatectomy during the prostate specific antigen era: implications fro screening a high-risk group for prostate carcinoma Cancer 92 2001 2673 2679
23. E.A. Bissonette, B.R. Fulmer, and G.R. Petroni Prostate specific antigen kinetics at recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men J Urol 166 2001 1328 1332
24. A.B. Jani, F. Vaidia, and G. Hanks Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era Int J Cancer 96 2001 363 371
25. O. Brawley Introduction Cancer and health disparities Cancer Metastasis Rev 22 2003 7 9
26. C.M. Moinpour, J.O. Atkinson, and S.M. Thomas Minority recruitment in the Prostate Cancer Prevention Trial Ann Epidemiol 10 8 Suppl 2000 S85 S91
27. P. Talone Establishing trust after Tuskegee Int J Radiat Oncol Biol Phys 40 1998 3 4
28. S.B. Robinson, M. Ashley, and A. Haynes Attitudes of African Americans regarding prostate cancer clinical trials J Community Health 21 1996 77 87
29. C. Royal, A. Baffoe-Bonnie, and R. Kittles Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) Study Ann Epidemiol 10 2000 S68 S77
30. K.R. Barber, R. Shaw, and M. Folts Differences between African American and caucasian men participating in a community-based prostate cancer screening program J Community Health 23 1998 441 451
31. I.M. Thompson, D.K. Pauler, and P.J. Goodman Prevalence of prostate cancer among men with a prostate-specific antigen level less than or equal to 4.0 ng per milliliter N Engl J Med 350 2004 2239 2246